Trial Profile
A phase I, randomized, open-Label, crossover study evaluating pharmacokinetics of Mirogabalin when coadministered with probenecid and cimetidine in healthy adult volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jul 2018
Price :
$35
*
At a glance
- Drugs Mirogabalin (Primary) ; Cimetidine; Probenecid
- Indications Neurogenic pain; Pain; Postherpetic neuralgia
- Focus Pharmacokinetics
- 19 Jun 2018 Results assessing the individual effects of probenecid and cimetidine on mirogabalin exposure published in the British Journal of Clinical Pharmacology
- 05 Apr 2017 New trial record
- 18 Mar 2017 Results evaluating pharmacokinetic interaction between Cimetidine with Mirogabalin, presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics